Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies
Multi-target inhibitors represent useful anticancer agents with superior therapeutic attributes. Here in, two novel series of benzimidazole-triazole hybrids were designed, synthesised as multi-target EGFR, VEGFR-2 and Topo II inhibitors, and evaluated for anticancer activity. Compounds 5a and 6g wer...
Saved in:
Main Authors: | Dina I. A. Othman (Author), Abdelrahman Hamdi (Author), Samar S. Tawfik (Author), Abdullah A. Elgazar (Author), Amany S. Mostafa (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Benzimidazole-Triazole Hybrids as Antimicrobial and Antiviral Agents: A Systematic Review
by: Maria Marinescu
Published: (2023) -
New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study
by: Mohammad M. Al-Sanea, et al.
Published: (2023) -
Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights
by: Abdelrahman Hamdi, et al.
Published: (2023) -
Synthesis, Biological Evaluation and In-silico ADME Study of Novel Hybridized Benzimidazole-Chalcone Compounds with Potential Antimicrobial Activity
by: Mai Shahin, et al.
Published: (2022) -
Benzimidazole-Based Schiff Base Hybrid Scaffolds: A Promising Approach to Develop Multi-Target Drugs for Alzheimer's Disease
by: Rafaqat Hussain, et al.
Published: (2023)